Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018
ConclusionsOne-third of local health departments reported no safety-net sexually transmitted disease services or were not aware of the services, and availability of specific services varied. Without an expansion of resources, local health departments might explore collaborations with healthcare systems and innovations in testing to expand sexually transmitted disease services.
Authors: Bergeron HC, Tripp RA Abstract Introduction. Respiratory syncytial virus (RSV) causes lower respiratory tract infections and can lead to morbidity and mortality in the infant, elderly and immunocompromised. There is no vaccine and therapeutic interventions are limited. RSV disease research has yielded the development of several prophylactic and therapeutic treatments. Several promising candidates are currently under investigation.Areas covered. Small and large molecule approaches to RSV treatment were examined and categorized by their mechanism of action using data from PubMed, clinicaltrials.gov, and from...
Publication date: April 2020Source: Fish &Shellfish Immunology, Volume 99Author(s): Mostafa Halimi, Mojtaba Alishahi, Mohammad Reza Abbaspour, Masoud Ghorbanpoor, Mohammad Reza Tabandeh
Okay, I'm not an epidemiologist or a virologist. But I do know something about those subjects, I'm a public health professor, and I am an expert in clinical communication and risk communication. So I'm going to offer some observations that I hope will help people keep this public health scare in proper perspective and maybe be of practical use.There are two important parameters we need to understand the risk caused by any communicable disease. I'm going to broadly say transmissibility, and the probability that exposure will lead to serious disease.We often see transmissibility represented as a single number, called R0 or &...
We report the case of an 84-year-old man with asymptomatic chronic hepatitis C virus (HCV) infection treated with direct antiviral agents. At the end of the antiviral therapy laboratory tests showed an abrupt increase in cholestasis parameters and aminotransferases, associated with anti-mitochondria antibodies positivity. Therefore, primary biliary cholangitis (PBC) was diagnosed. The patient was treated with ursodeoxycholic acid achieving a good biochemical response. This is the second case described in literature of PBC onset after HCV eradication with an interferon-free antiviral regimen. In both cases an autoimmune dam...
Wash your hands. Keep a good supply of essential medicines. Get a flu shot. Experts offer practical tips on how to get ready for a possible outbreak.
[Observer] Two individuals, Joseph Kintu and Sulaiman Balinya, have sued Marie Stopes Uganda for negligence after they used defective Lifeguard condoms that burst during sex, leading to the contraction of HIV/Aids.
[Daily Maverick] On 24 February, the Commission for Gender Equality launched its investigative report on forced sterilisation of women at KwaZulu-Natal and Gauteng hospitals. Among numerous horrendous revelations, the report brought to light inadequacies in the country's healthcare process to obtaining patients' consent.
CONCLUSIONS The expression of MyD88 and TRAF6 might vary in different stages of HPV infection. pDCs might regulate CD40 to participate in the tumorigenesis and progression of cervical cancer, but related mechanisms still need further investigation. PMID: 32089541 [PubMed - in process]
(Hong Kong University of Science and Technology) A team HKUST scientists has recently identified a set of potential vaccine targets for SARS-CoV-2 coronavirus, to guide experimental efforts towards vaccine development against novel pneumonia (COVID-19).
Conclusion: We observed high prevalence of HPV infection followed by trichomoniasis, while other STIs were rare among women in rural Nepal. There was no association between genitourinary symptoms and laboratory-confirmed STIs. PMID: 30224859 [PubMed - in process]